EPHA2 and breast carcinoma: Aberrant expression of EphA2 has been associated with many human malignancies, such as lung cancer (4), breast cancer (21), ovary cancer (22), esophageal cancer (7), colorectal cancer (23), glioblastoma (24), and melanoma (25).